Diabetech - Diabetes Tech, Research, News

Justin Eastzer
  • 4.8 (60)
  • Medicine
  • Updated Weekly

A diabetes technology podcast covering the latest diabetes news, research, treatments, and management tips. Through interviews with industry leaders, healthcare professionals, researchers, and people living with diabetes, we explore insulin pumps, continuous glucose monitors (CGMs), automated insulin delivery (AID) systems, clinical trials, emerging therapies, and advances in diabetes care. From product reviews to scientific breakthroughs and industry insights, Diabetech keeps you informed about the technology and research shaping the future of diabetes management.

  1. 6d ago

    Beta Bionics Mint - A New Tubeless Pump Coming in 2027

    Beta Bionics is bringing its AID technology to a new patch pump format with the FDA-cleared Mint, expected to launch in Q1 2027. Mike Mensinger, Chief Product Officer at Beta Bionics breaks down how Mint’s two-part design works, from its reusable controller, to a Mint site and smartphone app demo. Mensinger shares what’s changing with the iLet, including the upcoming 3D Intelligence algorithm and planned Eversense 365 integration. Lastly, we look ahead at Beta Bionics’ plans for future dual-hormone systems and how the Mint platform could help make those possibilities a reality.   Watch the Mint Post-Show episode   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (sponsor)*   Beta Bionics iLet Real World Data   Watch Next: Bluetooth Underwater | Artificial Pancreas   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

  2. Oct 12

    Trio & The Future of Open Source AID

    Trio version 1.0 is here! This is the largest system update to date for the open-source automated insulin delivery (AID) system. The latest release adds new pump and CGM integrations, a redesigned app, customizable alerts, glucose forecasts, and new features like Quick Picks. This episode explores how Trio’s open-source approach differs from commercial AID systems and how users can customize the system around their diabetes management needs. Contributors Teresa Hastings and Magnus Wrights also share how they use Trio, including approaches that can reduce the need for manual boluses and carbohydrate entries. The conversation also covers Trio’s algorithm, dynamic insulin sensitivity, Apple Watch and Garmin integration, upcoming pump integrations, and what could be next for open-source AID.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (sponsor)*   Resources: Triodocs Website  | Loop and Learn  | Hackathon fundraising    Listen to Diabetes Advocates: YouTube | Apple | Spotify   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. DIY apps are experimental and not approved by the FDA or regulatory authorities at the time of this video. You take full responsibility for building and using DIY apps and you do so at your own risk. Results will vary.   *Omnipod (today's sponsor): 30-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

  3. Oct 5

    Why Your Pump & CGM Stop Talking Underwater

    Your pump and CGM lose connection in the pool, and it comes down to centimeters. I sat down with Dr. Michael Hughes, an endocrinologist at Emory University, to break down his research on swimming with automated insulin delivery (AID). His team found the connection held at 100% at 10 cm, dropped to about half at 13 cm, and hit 0% by 17 cm, so where you place your pod and CGM matters a lot for swimming with type 1 diabetes. We also cover what limited mode does when your devices disconnect, and why starting glucose and insulin on board mattered more than connectivity for avoiding lows.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (sponsor)*   Listen to Diabetes Advocates: YouTube | Apple | Spotify   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

  4. Sep 28

    How to Master Your AID System - ODT

    Are you getting the most out of your automated insulin delivery system, or are you still managing it like a traditional insulin pump? Gary Scheiner, CDCES, and I break down 10 ways to optimize your AID system, from fine-tuning pump settings and knowing when to bolus to treating lows and timing insulin more effectively. We also cover how to trust the algorithm, use advanced pump features for exercise and meals, rotate infusion sites, and keep your CGM data reliable.   Learn about Omnipod 5 (today's sponsor)*   Learn about the Eversense 365 CGM   Integrated Diabetes - work with Gary's team   Optimizing Diabetes Tech Playlist   Listen to Diabetes Advocates (New Podcast): Apple | Spotify | YouTube   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

  5. Sep 21

    Libre Duo - The First Dual Glucose-Ketone Sensor

    Abbott's VP of Technical Operations and Senior Medical Director break down the new Libre Duo sensor, the first continuous glucose ketone monitor. We discuss the growing need for more ketone data, how ketone alerts will appear in the existing Libre app, and why the company designed the experience to minimize alert and information fatigue. The conversation also covers Libre Duo’s compatibility with leading automated insulin delivery systems.   Learn about Omnipod 5 (sponsor)*   Learn about the Eversense 365 CGM   Listen to Diabetes Advocates: YouTube | Apple | Spotify   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

  6. Sep 14

    The Cure for T1D - Inside the Eledon Trial

    Eledon's CEO, Dr. David-Alexandre Gros, breaks down Tegoprubart, the company’s targeted immunosuppressant being studied alongside islet cell transplants for type 1 diabetes. The conversation covers the promising results seen so far, including insulin independence and improved A1C levels among trial participants, and why Tego could offer a different approach to protecting transplanted cells. The episode also explores what the future of type 1 diabetes treatment could look like as transplantation, stem-cell-derived islets, and new immunosuppressive therapies continue to advance.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (sponsor)*   Watch Next: Type 1 Diabetes Cure Research    Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

  7. Sep 7

    Inside Europe’s Insulin Pump Market

    Ever wonder what insulin pump options exist outside the U.S.? Dr. Inge Van Boxelaer, a Belgian endocrinologist and founder of Diabetotech, joins us on the podcast and breaks down the European AID system landscape. We cover how MiniMed, Tandem, and Omnipod are performing across European markets, plus a deep dive into European systems like the Kaleido, mylife YpsoPump (with CamAPS FX and the upcoming Liberty algorithm), the Diabeloop-powered systems, and the Medtrum Touchcare. The conversation also explores how reimbursement and regulatory approval vary wildly by country, and where the market is headed next with patch pumps, phone-controlled systems, and fully closed-loop technology.   Learn about Omnipod 5 (sponsor)*   Learn about the Eversense 365 CGM   Check out Diabetotech   Podcast: Medtrum User Interview, CamAPS FX Explained   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

  8. Aug 31

    What Will a Type 1 Diabetes Cure Actually Look Like?

    Part two of this series continues the conversation about what a cure for type 1 diabetes could actually look like, from cell replacement and immune therapies to insulin innovation and advanced diabetes technology. The discussion explores islet cell transplants, stem cell-derived beta cells, immune suppression, gene-edited cells, and the challenges of making these approaches safer and more widely available. The expert panel also break down why even the most advanced technology today still falls short of a true cure. A major focus is accessibility, including who could benefit from these therapies, how much they might cost, and the infrastructure needed to deliver them to millions of people with type 1 diabetes. The experts discuss their vision for the future of cure research and how far off it could be.   Learn about Omnipod 5 (sponsor)*   Learn about the Eversense 365 CGM   Could Prevention be the Cure for Type 1 Diabetes?   The Cure Post-Show Reaction   Diabetech Feedback Survey   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

See All (177)

4.8
out of 5
60 Ratings

About

A diabetes technology podcast covering the latest diabetes news, research, treatments, and management tips. Through interviews with industry leaders, healthcare professionals, researchers, and people living with diabetes, we explore insulin pumps, continuous glucose monitors (CGMs), automated insulin delivery (AID) systems, clinical trials, emerging therapies, and advances in diabetes care. From product reviews to scientific breakthroughs and industry insights, Diabetech keeps you informed about the technology and research shaping the future of diabetes management.

Information

You Might Also Like